peroxynitrous acid has been researched along with cx 659s in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (cx 659s) | Trials (cx 659s) | Recent Studies (post-2010) (cx 659s) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 11 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furue, M; Goto, Y; Hayashi, H; Kogawa, N; Takahashi, O; Tsuchiya, M; Uchi, H; Watanabe, N | 1 |
1 other study(ies) available for peroxynitrous acid and cx 659s
| Article | Year |
|---|---|
CX-659S: a novel diaminouracil derivative that has antioxidative and acute anti-inflammatory activities.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arachidonic Acid; Ascorbic Acid; Chromans; Dose-Response Relationship, Drug; Ear; Edema; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Oxidation-Reduction; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Uracil | 2002 |